NO20052826L - Metodologi for a estimere konformasjon til et protein - Google Patents

Metodologi for a estimere konformasjon til et protein

Info

Publication number
NO20052826L
NO20052826L NO20052826A NO20052826A NO20052826L NO 20052826 L NO20052826 L NO 20052826L NO 20052826 A NO20052826 A NO 20052826A NO 20052826 A NO20052826 A NO 20052826A NO 20052826 L NO20052826 L NO 20052826L
Authority
NO
Norway
Prior art keywords
protein
conformation
methodology
estimating
structural properties
Prior art date
Application number
NO20052826A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052826D0 (no
Inventor
David Neil Cooper
Mark Lewis
Linda Fryklund
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2002/005112 external-priority patent/WO2003042245A2/en
Priority claimed from GBGB0226441.4A external-priority patent/GB0226441D0/en
Priority claimed from GB0308242A external-priority patent/GB0308242D0/en
Application filed by Univ Cardiff filed Critical Univ Cardiff
Publication of NO20052826D0 publication Critical patent/NO20052826D0/no
Publication of NO20052826L publication Critical patent/NO20052826L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
NO20052826A 2002-11-12 2005-06-10 Metodologi for a estimere konformasjon til et protein NO20052826L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/GB2002/005112 WO2003042245A2 (en) 2001-11-12 2002-11-12 Growth hormone variations in humans and their uses
GBGB0226441.4A GB0226441D0 (en) 2002-11-12 2002-11-12 Growth hormone variation in humans and their uses
GB0308242A GB0308242D0 (en) 2003-04-10 2003-04-10 Growth hormone variations in humans and their uses
GBGB0308238.5A GB0308238D0 (en) 2002-11-12 2003-04-10 Proteolysis methodology
PCT/GB2003/004740 WO2004044230A1 (en) 2002-11-12 2003-11-04 A methodology of estimating the conformation of a protein by proteolysis

Publications (2)

Publication Number Publication Date
NO20052826D0 NO20052826D0 (no) 2005-06-10
NO20052826L true NO20052826L (no) 2005-07-26

Family

ID=34680426

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20052826A NO20052826L (no) 2002-11-12 2005-06-10 Metodologi for a estimere konformasjon til et protein
NO20052815A NO20052815L (no) 2002-11-12 2005-06-10 Veksthormonvarianter hos mennesket og deres anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20052815A NO20052815L (no) 2002-11-12 2005-06-10 Veksthormonvarianter hos mennesket og deres anvendelse

Country Status (9)

Country Link
US (2) US20060166209A1 (de)
EP (2) EP1560849A1 (de)
JP (2) JP2006505289A (de)
KR (2) KR20050086467A (de)
AU (2) AU2003276464A1 (de)
CA (2) CA2503626A1 (de)
HR (2) HRP20050425A2 (de)
NO (2) NO20052826L (de)
WO (2) WO2004044230A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1

Also Published As

Publication number Publication date
AU2003276464A1 (en) 2004-06-03
AU2003279451A1 (en) 2004-06-03
EP1560849A1 (de) 2005-08-10
WO2004044230A1 (en) 2004-05-27
WO2004044002A1 (en) 2004-05-27
US20060166210A1 (en) 2006-07-27
EP1560922A1 (de) 2005-08-10
KR20050084951A (ko) 2005-08-29
JP2006505289A (ja) 2006-02-16
CA2503672A1 (en) 2004-05-27
KR20050086467A (ko) 2005-08-30
HRP20050425A2 (en) 2005-12-31
NO20052815D0 (no) 2005-06-10
US20060166209A1 (en) 2006-07-27
NO20052826D0 (no) 2005-06-10
JP2006523089A (ja) 2006-10-12
NO20052815L (no) 2005-08-03
CA2503626A1 (en) 2004-05-27
HRP20050426A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
WO2004092199A3 (en) Method for identifying modulators of g protein coupled receptor signaling
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
ATE439742T1 (de) Verfahren und vorrichtung zur verschleierung von zeitfehlern in einem p-rahmen
PT1117999E (pt) Caracterizacao de polipeptidos por clivagem e por espectrometria de massa
WO2008030887A3 (en) Methods for designing parp inhibitors and uses thereof
IL217489A0 (en) Protease screening methods and proteases identified thereby
NO20050144L (no) Fremgangsmate for a fremstille substituerte pyrimidiner
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
WO2002072778A3 (en) Method for identifying inhibitors of g protein coupled receptor signaling
MY145455A (en) Diagnostic biomolecule(s)
NO20052826L (no) Metodologi for a estimere konformasjon til et protein
TW200518761A (en) Enteropathy improving composition
WO2005031004A3 (de) Verfahren zum spezifischen schnellnachweis getränkeschädlicher mikroorganismen
IL182383A0 (en) Double hybrid system based on gene silencing by transcriptional interference
WO2006096697A3 (en) Methods for determining the bivalency of protein and antibody therapeutics
NO20053990L (no) Assay for proteinisoformer
WO2004099784A3 (en) Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
AU2003233292A1 (en) Protein c polymorphisms
WO2006044686A3 (en) Methods and compositions for predicting drug responses
WO2006034335A3 (en) Method of detecting cancer based on immune reaction to boris
HK1073671A (en) A methodology of estimating the conformation of a protein by proteolysis
ATE543429T1 (de) Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür
DE60332158D1 (de) Verfahren zur herzerkrankungsbewertung in einer einzelperson
AU2003288249A1 (en) Method for detecting the presence and determining the concentration of sulfur-free odorants in natural or combustible gas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application